Compare · HWH vs MCK
HWH vs MCK
Side-by-side comparison of HWH International Inc. (HWH) and McKesson Corporation (MCK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HWH and MCK operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- MCK is the larger of the two at $101.08B, about 9212.9x HWH ($11.0M).
- Over the past year, HWH is down 3.4% and MCK is up 19.2% - MCK leads by 22.6 points.
- MCK has hit the wire 13 times in the past 4 weeks while HWH has been quiet.
- MCK has more recent analyst coverage (25 ratings vs 0 for HWH).
- Company
- HWH International Inc.
- McKesson Corporation
- Price
- $1.42+11.81%
- $841.14+1.99%
- Market cap
- $11.0M
- $101.08B
- 1M return
- +4.80%
- +9.73%
- 1Y return
- -3.40%
- +19.21%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 0
- 13
- Recent ratings
- 0
- 25
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Latest HWH
- SEC Form D filed by HWH International Inc.
- SEC Form DEF 14C filed by HWH International Inc.
- SEC Form PRE 14C filed by HWH International Inc.
- Chief Executive Officer Chan Heng Fai Ambrose bought $500,000 worth of shares (250,000 units at $2.00) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by HWH International Inc.
- HWH International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- HWH International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- HWH International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form 10-Q filed by HWH International Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by HWH International Inc.
Latest MCK
- McKesson Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 4 filed by Director Hinton James H.
- SEC Form 4 filed by Director Doughtie Lynne M
- Director Wilson-Thompson Kathleen was granted 277 shares, increasing direct ownership by 92% to 578 units (SEC Form 4)
- SEC Form 4 filed by Director Dunbar Webster Roy
- Director Caruso Dominic J was granted 277 shares, increasing direct ownership by 43% to 927 units (SEC Form 4)
- SEC Form 4 filed by Director Gerberding Julie L.
- SEC Form 4 filed by Director Lerman Bradley E
- Director Martinez Maria was granted 277 shares, increasing direct ownership by 92% to 578 units (SEC Form 4)
- SEC Form 4 filed by Director Ozan Kevin M